IndraLab
Statements
USP8 activates cell growth. 14 / 17
|
14
reach
"DUB-IN-1 and its analogs inhibited the growth of colon and prostate cancer cells, with IC s ranging 0.5–1.5 µM. Novel USP8 inhibitors were further discovered and exhibited anticancer efficiency, and treatment with the USP8 inhibitor or siRNA targeting USP8 was reported to inhibit HER-3-positive gastric cancer cell growth [14]."
reach
"As USP8 silencing significantly inhibited the PCa cell growth, proliferation, and metastasis and induced apoptosis and suppressed NF-kB signal activation by decreasing EGFR and PI3K, the USP8-specific inhibitor might be a novel therapeutic target to suppress PCa cell growth, proliferation, and metastasis."